Related Experiment Video
Updated: Aug 7, 2026
04:28
Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
Pharmacists in veterinary education: bridging the gap
Margo Karriker1, Valerie Wiebe
1Clinical Pharmacy Coordinator, Department of Pharmacy, University of California, Davis, CA 95616, USA. mjkarriker@vmth.ucdavis.edu
Journal of Veterinary Medical Education
|July 20, 2006
Summary
Collaboration between pharmacy and veterinary medicine enhances patient care. Integrating pharmaceutical education into veterinary curricula ensures better drug therapy evaluation and practice management for improved animal health outcomes.
Area of Science:
- Veterinary Medicine
- Pharmacy
- Comparative Medicine
- Drug Therapy Management
Background:
- Veterinary patients can significantly benefit from enhanced collaboration between the pharmacy and veterinary medicine professions.
- Current educational models may not fully prepare professionals for interdisciplinary practice.
- Understanding the distinct roles and capabilities of each profession is crucial for effective collaboration.
Purpose of the Study:
- To explore the synergistic potential between pharmacy and veterinary medicine for improved patient outcomes.
- To advocate for revisions in veterinary and pharmacy education to foster interprofessional collaboration.
- To define essential skills for veterinarians in drug therapy evaluation and practice management.
Main Methods:
- Analysis of current veterinary and pharmacy educational frameworks.
- Identification of key areas for curriculum integration between the two professions.
- Conceptualizing an optimal learning environment that promotes interdisciplinary understanding.
Main Results:
- Veterinary education should equip students with skills for critical drug therapy evaluation using reliable sources.
- Veterinarians need to understand legal, regulatory, and operational requirements for drug dispensing.
- Incorporating pharmaceutical knowledge into veterinary training enhances practice readiness.
Conclusions:
- Integrating pharmacy and veterinary medicine education is vital for advancing quality patient care.
- Mutual understanding between professions enables veterinarians to leverage pharmaceutical expertise effectively.
- Collaborative educational approaches lead to superior patient care and professional development.
Related Concept Videos
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...